T-POC Quantitative Testing Platform – Product Brochure
SurfaceSurvey(TM) – OSD Patient Questionnaire
Peer-Reviewed Article entitled “How Can We Best Diagnose Severity Levels of Dry Eye Disease: Current Perspectives“; Chester T. et al. Clinical Ophthalmology 2023 Jun 5;17:1587-1604.
Interpretation and Application of T-POC Quantitative Testing Results
T-POC Lateral Flow Reader Overview & Troubleshooting Guide
Lateral Flow Reader – Instructions for Use
Biovance 3L Ocular – Overview Sheet
Biovance 3L Ocular – Clinical Application Process
Biovance 3L Ocular – Clinical Application Process [VIDEO]
Biovance 3L Ocular – Order Form
Biovance 3L Ocular – Insurance Verification Form
Biovance 3L Ocular – 2023 Medicare Billing Codes and Payment Information
Biovance 3L Ocular – Benchtop Study Reprint
Biovance 3L Ocular – Case Study – Anterior Membrane Dystrophy
Peer-Reviewed Article entitled “An in vitro comparison of human corneal epithelial cell activity and inflammatory response on differently designed ocular amniotic membranes and a clinical case study”; Mao Y. et al; J Biomed Mater Res. 2022;1–17.
Peer-Reviewed Article entitled “Surgical Time and Postoperative Symptoms Study in Pterygium Excision and Amniotic Membrane Graft Using Celularity Triple Layer Dehydrated Amniotic Membrane“; Rivera-Morales P. et al; Clin Ophthal 2023:17;1967-1974. https://doi.org/10.2147/OPTH.S410452
Ophthalmology Times Article – Novel Amniotic Membrane: A Step Ahead of Other Scaffolds for Pterygia
Opthalmology Times Article – 3-layer amniotic membrane successfully treats severe case of keratoconjunctivitis sicca
Healio Article – Biovance 3L Ocular effective in patients with chronic ocular surface disease
© 2022 Verséa Health, Inc. All rights reserved.
Meet with Verséa Ophthalmics at the 2023 American Academy of Optometry Annual Meeting to learn more about how you can
We look forward to meeting with you in New Orleans!